A detailed history of Tobam transactions in United Therapeutics Corp stock. As of the latest transaction made, Tobam holds 37,941 shares of UTHR stock, worth $13.8 Million. This represents 2.48% of its overall portfolio holdings.

Number of Shares
37,941
Previous 56,258 32.56%
Holding current value
$13.8 Million
Previous $17.9 Million 24.13%
% of portfolio
2.48%
Previous 2.81%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$311.04 - $363.55 $5.7 Million - $6.66 Million
-18,317 Reduced 32.56%
37,941 $13.6 Million
Q2 2024

Jul 29, 2024

SELL
$228.26 - $319.04 $12 Million - $16.7 Million
-52,389 Reduced 48.22%
56,258 $17.9 Million
Q1 2024

May 02, 2024

SELL
$210.76 - $249.51 $1.08 Million - $1.27 Million
-5,110 Reduced 4.49%
108,647 $25 Million
Q4 2023

Jan 26, 2024

SELL
$214.88 - $256.94 $6.8 Million - $8.14 Million
-31,663 Reduced 21.77%
113,757 $25 Million
Q3 2023

Oct 31, 2023

SELL
$211.82 - $248.24 $650,922 - $762,841
-3,073 Reduced 2.07%
145,420 $32.8 Million
Q2 2023

Jul 31, 2023

SELL
$205.19 - $232.99 $4.4 Million - $4.99 Million
-21,430 Reduced 12.61%
148,493 $32.8 Million
Q1 2023

May 03, 2023

BUY
$212.99 - $276.17 $12.9 Million - $16.7 Million
60,639 Added 55.49%
169,923 $38.1 Million
Q4 2022

Feb 02, 2023

BUY
$205.95 - $280.43 $14 Million - $19 Million
67,767 Added 163.23%
109,284 $30.4 Million
Q3 2022

Nov 02, 2022

BUY
$203.3 - $244.17 $7.67 Million - $9.22 Million
37,750 Added 1002.12%
41,517 $8.69 Million
Q2 2022

Aug 02, 2022

BUY
$174.81 - $241.14 $658,509 - $908,374
3,767 New
3,767 $888,000
Q1 2019

May 15, 2019

SELL
$107.15 - $126.84 $1.83 Million - $2.17 Million
-17,080 Closed
0 $0
Q4 2018

Feb 11, 2019

SELL
$101.4 - $128.73 $1.92 Million - $2.43 Million
-18,915 Reduced 52.55%
17,080 $1.86 Million
Q3 2018

Nov 08, 2018

SELL
$113.81 - $129.46 $928,348 - $1.06 Million
-8,157 Reduced 18.47%
35,995 $4.6 Million
Q2 2018

Aug 03, 2018

BUY
$101.14 - $118.31 $897,516 - $1.05 Million
8,874 Added 25.15%
44,152 $5 Million
Q1 2018

May 14, 2018

BUY
$107.21 - $151.94 $325,382 - $461,137
3,035 Added 9.41%
35,278 $3.96 Million
Q4 2017

Feb 14, 2018

SELL
$118.58 - $151.28 $4.17 Million - $5.32 Million
-35,156 Reduced 52.16%
32,243 $4.77 Million
Q3 2017

Nov 14, 2017

SELL
$114.6 - $136.81 $40,797 - $48,704
-356 Reduced 0.53%
67,399 $7.9 Million
Q2 2017

Aug 08, 2017

BUY
N/A
67,755
67,755 $8.79 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Tobam Portfolio

Follow Tobam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

News

Stay updated on Tobam with notifications on news.